throbber
Effective methods of in-line intravenous fluid
`warming at low to moderate infusion rates
`
`Lt Col C. CARL BOSTEK, CRNA, MSN, USAF, NC
`Minot Air Force Base, North Dakota
`
`Three methods of warming intravenous (IV)
`fluids were examined. An in-line blood
`warmer was generally ineffective at flow rates
`of< 250 mL/hr but did produce temperatures
`of 80 to 310C at the catheter when the infusion
`rate was 500 to 1,000 mL/hr and the tubing was
`insulated. An in-line hot water bath
`- 30°C at flow rates
`produced temperatures of
`of200 to 1,000 mL/hr with uninsulated tubing.
`The addition of insulation maintained an
`infusate temperature of 30°C at a rate of
`100 mL/hr. Application of a K-Thermia®
`pad to the IV tubing close to the patient
`maintained an infusate temperature of 2 300 C
`at rates of 50 to 200 mL/hr. Warming at rates
`of 200 to 1,000 mL/hr is most effective with an
`in-line hot water bath. Warming at low
`infusion rates is best accomplished with a
`K-Thermia pad. The use of in-line blood
`warmers for routine fluid warming is
`ineffective.
`Key words: Hypothermia prevention,
`intravenous fluid temperature,
`intravenous fluid warming.
`
`Introduction
`The incidence of hypothermia has been reported
`to be as high as 60% during elective surgery.' De-
`creased oxygen delivery resulting from a left shift
`of the oxyhemoglobin dissociation curve, de-
`creased tissue perfusion secondary to vasoconstric-
`
`tion, an increased incidence of deep vein thrombo-
`sis and pulmonary embolism, increased plasma
`levels of catecholamines and thyroid hormones,
`coagulopathy, increases in oxygen consumption
`during light general anesthesia, increases in car-
`bon dioxide production and oxygen consumption
`up to 300% as a result of shivering, and, possibly,
`prolonged emergence and recovery from anesthe-
`sia are all potential sequelae of hypothermia.2.
`Causes of hypothermia in the operating room
`include the use of unwarmed intravenous (IV) and
`irrigation solutions, unheated dry gases, low room
`temperatures, and the administration of drugs
`which impair thermoregulation. The metabolic
`cost of heating unwarmed fluids is approximately
`16% of basal heat production when fluid require-
`ments reach 6 mL/kg per hour in a 70-kg patient.2
`This level is readily exceeded when infusion rates
`are increased to compensate for decreases in blood
`pressure or periods of increased blood loss. Thus,
`the body heat expended to warm IV fluids admin-
`istered at room temperature is a significant por-
`tion of basal heat production.
`Heat loss can be reduced by preheating IV
`fluids or by in-line warming during administra-
`tion. But neither method provides near body tem-
`perature infusate unless flow rates are - 1 L/hr.4-7
`Allowing for basal metabolic requirement, 6 mL/kg
`per hour for interstitial losses, and replacement of
`nothing by mouth induced fluid deficit over 3
`hours, the fluid requirement during the first 3
`hours of a major abdominal case will approximate
`850 mL/hr in a 70-kg patient. This infusion rate is
`
`December 1992/ Vol. 60/No. 6
`
`561
`
`Reactive Surfaces Ltd., LLP Ex. 1009 - Page 1
`
`

`
`too slow to provide near body temperature infusate
`when using preheated fluids or an in-line blood
`warmer.
`The purpose of this study was to evaluate the
`effectiveness of two alternative in-line warming
`techniques at loss infusion rates. Warming was ac-
`complished by immersing IV tubing in a high-
`temperature water bath or by wrapping a K-Ther-
`mia® pad around the IV tubing close to the inser-
`tion site. Results of warming by these methods were
`compared with in-line warming using a common
`blood warmer.
`Methods and procedures
`In all groups, a Mon-a-therm® Model 6000
`(Mon-A-Therm, Inc., St. Louis, Missouri) with a
`specially modified skin sensor probe was used to
`measure temperature at the distal end of the IV
`extension tubing by threading the probe into an
`Extension Set with "T" (Abbott Hospitals, Inc.,
`North Chicago, Illinois) (Figure 1). Flow rates of
`50, 100, 150, 200, 250, 500, and 1,000 mL/hr were
`
`Figure I
`Distal end of infusion setup
`
`Modified skin temperature probe has been inserted under the
`rubber stopper into the T-piece to simulate measurement
`of infusate temperature at the catheter site. An extension tube
`was attached to the distal end of the T-piece to prevent
`evaporation of infusate at that point.
`
`achieved using an AVI GuardianTM 100 Infusion
`Pump (AVI, Inc., St. Paul, Minnesota) positioned
`between the IV bag and the heating device. A flow
`rate of 6,000 mL/hr was the maximum attained
`through unrestricted IV tubing.
`For Group I, fluids were warmed by passing
`them through a Pharmaseal® warming coil
`(Pharmaseal Co., Valencia, California) in a Phar-
`maseal DW 1000 Blood Warmer (Table I). In
`Group Ia, a single length of Pharmaseal K50L ex-
`tension tubing (capacity 3.3 mL, length 84 cm) and
`a Pharmaseal K52 extension tube with stopcock
`were attached to the distal end of the coil. In Group
`Ib, only a K52 was attached, and in Group Ic, a
`K52 was insulated with a strip of "egg crate" foam
`insulation (E.R. Carpenter Co., Medical Products
`Division, Russellville, Kentucky).
`In Group II, half the length of a K50L exten-
`sion tubing was coiled into a water bath (Marquest
`Medical Products, Inc., Englewood, Colorado)
`heated by an MR 430 Servo Controlled Heated Re-
`spiratory Humidifier set at 37 0 C (Isothermal/
`Fisher & Paykel, Ltd., Riverside, California). The
`actual temperature of the water was 650 C. Approx-
`imately 38 cm of the extension tube was distal to
`the water bath. In Group IIa, the tubing distal to
`the bath was exposed to room air, while in Group
`IIb, it was insulated with a strip of blue foam insu-
`lation. To test for the presence of plasticizer-the
`chemical responsible for the flexibility of IV bags
`and tubing-an extension tube was filled with
`preservative-free sterile water and heated for 8
`hours. The heated infusate was then spectrophoto-
`metrically scanned at wavelengths from 200 to
`750 nm.
`For Group III, a single length of K50L exten-
`sion tubing was coiled inside a 20 x 30-cm K-Ther-
`mia Pad heated by an Aquamatic K-Thermia
`Model RK-600 (Gorman-Rupp Industries, Bell-
`ville, Ohio) which had been folded in half along its
`length and again along its width to form a pad
`approximately 10 x 15 cm. In Group IIIa, the
`heater was set to 38 0 C, and the T-piece was left
`exposed to room air. In Group IIIb, the heater was
`set to 410 C, and the T-piece was again left exposed
`
`Table I
`Summary of warming methods and insulation used by groups and subgroups
`Group I
`Group II
`Warming method
`Pharmaseal warmer
`Water bath
`Subgroup
`a
`c
`b
`a
`b
`Tubing plus extensions K50/K52
`K52
`K52
`38 cm
`38 cm
`Insulation
`-
`-
`Foam
`-
`Foam
`
`Group III
`K-Thermia
`b
`at 41°C
`10 cm
`-
`
`a
`at 370C
`10 cm
`-
`
`c
`at 41°C
`10 cm
`Pad
`
`Journal of the American Association of Nurse Anesthetists
`
`Reactive Surfaces Ltd., LLP Ex. 1009 - Page 2
`
`

`
`to room air. In Group IIIc, the heater was set to
`41 0 C, but the T-piece was surrounded by the
`K-Thermia pad.
`In all groups, the IV solution had been stabi-
`lized overnight at room temperature, and in-line
`temperatures were allowed to stabilize for 5 to 10
`minutes after changes in flow rate. Five tempera-
`tures were recorded at 15-second intervals for each
`flow rate. Room and IV bag temperatures ranged
`from 21.3 to 23.10 C.
`Results
`SPSS 4.0 (Statistical Package for Social Sci-
`ences, version 4.0) on a DEC VAX/VMS was used
`for statistical analysis. Analysis of variance revealed
`statistically significant differences among the
`groups at the .05 level. The Tukey-B procedure
`was used for pairwise comparisons. Statistically sig-
`nificant differences are summarized in Table II. In
`the following discussion, temperature measure-
`ments are reported as means plus or minus (±) one
`standard deviation.
`In Group I, the most effective warming oc-
`curred when a single extension tube was used and
`insulation was applied from the warming coil to
`the insertion site (Figure 2). Fluid temperatures at
`the catheter when using the Pharmaseal blood
`warmer with insulation and a single extension tube
`were never above 30 0C at low or moderate flow
`rates. At a rate of 1 L/hr, the infusate temperature
`at the catheter was 30.72 ± .22 0 C with two exten-
`sion tubes and no insulation, 30.66 ± .110 C with
`an uninsulated K52 extension, and 30.54 ± .060 C
`with an insulated K52 extension. Increasing the
`flow rate through the blood warmer to 6 L/hr pro-
`duced infusate temperatures at the catheter of
`33.64 ± .060C with two extension tubes and no in-
`sulation, 33.68 ± .130 C with an uninsulated K52
`extension tube, and 34.54 ± .11 0C with an insu-
`lated K52 extension. Except for flow rates of 50,
`100, and 1,000 mL/hr, the use of insulation with
`only a K52 extension tube provided significantly
`greater warming (P< .05).
`In Group II,
`the most effective heating oc-
`curred when insulation was applied to the exten-
`sion tube leading from the water bath (Figure 3).
`Infusate temperatures 2 30 0C at the catheter were
`achieved with the water bath and uninsulated tub-
`
`Figure 2
`Mean (± 1 standard deviation) temperatures of
`intravenous infusate at the catheter site after warming
`with an in-line blood warmer
`Temperature (°C)
`32
`
`30
`
`28
`
`26
`
`22-
`
`24
`
`--
`--
`
`Group la
`-- Group lb
`Group Ic
`
`20
`
`,
`,
`0 100 200 300 400 500 600 700 800 900 1000 1100
`Flow rates (mL/hr)
`Group la-Two extension tubes and a T-piece
`Group Ib-One extension tube and a T-piece
`Group Ic-Insulation added to one extension tube and
`T-piece
`
`ing at flow rates of 200 to 1,000 mL/hr. When the
`30 0 C were
`tubing was insulated, temperatures -
`achieved with flow rates of 100 to 1,000 mL/hr. The
`warmest temperature attained was 38 ± .040 C at a
`flow of 500 mL/hr. The use of insulation provided
`significantly greater heat retention at all flow rates
`from 50 to 500 mL/hr (P< .05).
`In Group III, warming was most effective
`when the K-Thermia pad completely covered the
`extension tube and insertion site (Figure 4). The
`lowest flows provided the most effective warming:
`infusate temperature was 38.4 ± .040 C at 50 mL/hr,
`.04 0 C at 100 mL/hr, 32.1 ±
`.070 C at
`34.2 ±
`150 mL/hr, and 30.1 ± .07 0C at 200 mL/hr. The use
`of a warming temperature of 41 0 C with the exten-
`sion tube provided significantly greater warming
`at rates of 50, 100, and 150 mL/hr (P< .05).
`Discussion
`Warming of IV fluids is traditionally accom-
`plished by preheating the bottles in warming cabi-
`
`Table II
`ANOVA showed these warming methods to be significantly different at the .05 level at the Infusion rates Indicated.
`Water bath
`Warmer
`---, 100,150, 200, 250, 500,1000, 6000
`50, 100,150, 200, 250, 500
`
`Water bath
`K-Thermia
`
`50, 100, --, 200, 250, 500
`
`December 1992/ Vol. 60/No. 6
`
`563
`
`Reactive Surfaces Ltd., LLP Ex. 1009 - Page 3
`
`

`
`Figure 3
`Mean (± 1 standard deviation) temperatures of
`intravenous infusate at the catheter site after warming
`with an in-line hot water bath
`Temperature (°C)
`40
`
`Figure 4
`Mean (± 1 standard deviation) temperatures of
`intravenous Infusate at the catheter site after warming
`with a K-Thermla pad
`Temperature (°C)
`40
`
`38
`
`36
`
`34
`
`32
`
`30
`
`28
`
`26
`
`24-
`
`22
`
`----
`
`Group Ila
`S---- Group lb
`
`38
`
`36
`
`34
`
`32
`
`30
`
`28
`
`26
`
`24
`
`22
`
`-
`
`--
`
`---
`
`-
`
`-
`--
`
`Group Ilia
`Group IIIb
`Group llic
`
`0
`
`100 200 300 400 500 600 700 800 900 1000 1100
`Flow rates (mL/hr)
`Approximately 40 cm of the first extension tube was
`threaded into the hot water bath. The remaining tubing
`was long enough to reach from the bath to a patient.
`Group la-One extension tube plus T-piece
`Group Ib-lnsulation added to one extension tube
`plus T-piece
`
`nets or running the IV tubing through an in-line
`blood warmer. Neither of these methods has
`proven completely satisfactory. This study exam-
`ined the effectiveness of insulating the tubing be-
`tween an in-line blood warmer, use of a hot water
`bath with minimal tubing between the bath and
`the patient, and use of a K-Thermia pad to pro-
`duce near body temperature infusate at the cathe-
`ter. Norman, Ahmad, and Zeig warmed bags of
`crystalloid in warming cabinets to 500 C and found
`that, over 1 hour, the temperature of infusate at the
`catheter decreased linearly from 37 to 310 C when
`the infusion was run at 1,000 mL/hr. Solution that
`was heated initially to 60 0 C decreased in tempera-
`ture at the catheter from 36.5 to 310 C after 1 hour
`and 27 0 C after 2 hours when run at 500 mL/hr.
`The tubing length was 275 cm, infusion pumps
`were not used, and the ambient room temperature
`was 23 to 250 C.5
`
`20
`
`0
`100
`200
`300
`400
`500
`600
`Flow rates (mL/hr)
`Group Illa-Heater set to 380C with the T-piece exposed
`to room air
`Group Illb-Heater set to 41 °C with the T-piece exposed
`to room air
`Group Illc-Heater was set to 41 °C but the T-piece was
`surrounded by the pad
`
`Skrivanek and Hein infused crystalloid solu-
`tions through a Pharmaseal blood warmer at rates
`of 1 to 12 L/hr. Ambient room temperature was
`20.4 to 20.90C. The temperature at the catheter site
`was 260 C when the infusion rate was 1 L/hr, 32.5 0 C
`at 2.4 L/hr, 29 0 C at 6 L/hr, and 26°C at 12 L/hr
`with two extension tubes attached to the IV tubing.
`With no extension tubes, the temperatures at the
`infusion site were 27.5 0 C, 310 C, 32 0 C, and 270C,
`respectively. An attempt to prevent heat loss by
`wrapping the IV tubing between the blood warmer
`and catheter with aluminum foil failed to increase
`infusate temperatures.6
`Aldrete also investigated the effect of infusion
`rate and tubing length on the temperature of
`infusate at the catheter site. The temperature of
`infusate at the catheter remained approximately
`250°C throughout the infusion period when the bag
`was warmed initially to 34.4 0 C and the infusion
`
`564
`
`Journal of the American Association of Nurse Anesthetists
`
`Reactive Surfaces Ltd., LLP Ex. 1009 - Page 4
`
`

`
`rate was set to 100 mL/min (6 L/hr) using an IVAC
`pump. When infused at 20 mL/min (1.2 L/hr), the
`temperature at the catheter remained approxi-
`mately 23°C. Warming the bags to 41.4°C provided
`an infusate temperature of 33.5°C at the catheter
`(100 mL/min) when the IV tubing was 180 cm long.
`Increasing the tubing length to 230 cm decreased
`the temperature of the infusate to approximately
`31.8°C. When bags were heated to 42.8°C and the
`fluid passed through a blood warmer at 36°C, the
`temperature of infusate at the catheter was 28 to
`30°C. Significant heat was lost from the IV fluid,
`since the blood warmer was cooler than the
`infusate.7
`Regardless of the method, preheating IV
`fluids only provides infusate temperatures - 30°C
`when the initial fluid temperature is ? 40°C
`and flow rates exceed 500 mL/hr. This occurs be-
`cause the large surface area of IV tubing allows
`rapid cooling of warm fluids. And since surface
`area varies directly with tubing length, the use of
`extensions will speed cooling. Furthermore, blood
`warmers are generally ineffective in providing
`body temperature infusate at the catheter because
`of the distance between the warmer outlet and the
`catheter site and because the warmer only reaches
`a temperature of approximately 37°C. The use of
`foam insulation slows heat loss from tubing, but
`this is of no clinical significance at low rates.
`The K-Thermia pad warms the air surround-
`ing the IV tubing. The heat in the air is conducted
`across the tubing to the fluid, making for an ineffi-
`cient warming system. The pad provides good
`warming at low rates if there is no exposed tubing,
`because low flows allow plenty of time for the
`infusate to warm. At higher flows, the pad is inef-
`fective, largely because of the poor heat conduc-
`tion.
`The water bath is the most efficient warming
`system studied, because of the high temperature of
`the bath and the excellent heat conduction between
`the water and the tubing. It provides for near body
`temperature infusate over the widest range of tem-
`peratures (Figure 5). However, a potential problem
`with this technique was recognized when the IV
`tubing in the bath was seen to become opaque with
`prolonged heating, raising the possibility that plas-
`ticizer would diffuse into the IV fluid.
`Plasticizers are important components of many
`plastic articles used in medical practice because
`they provide flexibility. Plasticizers, especially the
`phthalates, have been tested extensively in animal
`models and have been found safe when ingested
`orally. Phthalate plasticizers, however, will kill
`myocardial cells in tissue culture and can induce
`acute respiratory distress when injected IV at doses
`
`Figure 5
`Comparison of mean (± 1 standard deviation)
`temperatures of intravenous infusate at the catheter
`site after warming with the most effective method
`from each group
`Temperature (°C)
`39-
`
`37
`
`35
`
`33
`
`31
`
`29
`
`27
`
`25
`
`23
`
`21 1.
`
`-----
`
`Group Ic at 20°C
`SGroup Ilb at 20°C
`Group Illc at 20°C
`
`19
`
`0 100 200 300 400 500 600 700 800 900 1000 1100
`Flow rates (mL/hr)
`In-line blood warmer with one extension
`Group Ic-
`tube plus T-piece, insulated.
`Group lib-In-line hot water bath, one extension tube
`plus T-piece, insulated.
`Group Illc-K-Thermia pad covering all tubing and set
`to 41°C.
`
`of 200 mg/kg of body weight.'!' Blood and plasma
`proteins will leach plasticizer from intravenous
`bags and tubing made from polyvinyl chloride
`(PVC), but crystalloid solutions will not."10- 2 Fur-
`thermore, microwave warming of plastic IV bags
`containing crystalloid solutions shows no increase
`in plasticizer concentration when compared to con-
`trol fluids at room temperature. ':
`In this study, IV tubing filled with sterile water
`was heated in the water bath for 8 hours. Spectro-
`photometric analysis showed no change in optical
`density of the heated solution when compared with
`sterile water that was not heated in IV tubing. This
`observation, though not definitive, makes it seem
`unlikely that leaching of plasticizer into heated IV
`tubing is a major problem.
`No single method of warming IV fluids can
`provide body temperature infusate at the catheter
`
`December 1992/ Vol. 60/No. 6
`
`565
`
`Reactive Surfaces Ltd., LLP Ex. 1009 - Page 5
`
`

`
`at all flow rates. Flow rates in excess of 1 L/hr are
`common in resuscitation efforts, and the infusion
`of fluids prewarmed to 500 C effectively provides
`infusate temperatures near 370C at the catheter.'
`But flow rates of 200 to 600 mL/hr are more com-
`mon during major elective surgery in adults, while
`even lower flows are associated with pediatric
`patients.
`
`Conclusions
`1. There is no single method for warming IV
`fluids that will provide near body temperature
`infusate at all flow rates.
`2. The Pharmaseal DW 1000 blood warmer is
`ineffective in providing near body temperature
`infusate when used with long extension tubing.
`3. A hot water bath located close to the infu-
`sion site is the most effective means of providing
`near body temperature infusate at flow rates of
`100 to 1,000 mL/hr if exposed tubing is insulated
`with foam. Warming is effective at rates from
`250 to 1,000 mL/hr when exposed tubing is not
`insulated.
`4. A K-Thermia pad applied around the tub-
`ing and close to the insertion site provides near
`body temperature infusate at or below 100 mL/hr.
`
`Clinical recommendations
`1. The first bottle of IV fluid given when a
`patient comes to surgery should be prewarmed,
`since that bottle is usually infused in less than 1
`hour.
`2. Loss of body temperature from the infusion
`of cold IV fluids will be minimized by using a
`single intravenous site for administration of
`
`warmed maintenance fluids while keeping veins
`open at other available sites.
`REFERENCES
`(1) Vaughan MS, Vaughan RW, Cork RC. Postoperative hypothermia
`in adults: Relationship of age, anesthesia, and shivering to rewarming.
`AnesthAnalg. 1981;60:746-751.
`(2) FlackeJW, Flacke WE. Inadvertent hypothermia: Frequent, insidi-
`ous, and often serious. Seminars in Anesthesia. 1983;2:183-196.
`(3) Reed HL, Chernow B, Lake CR, et al. Alterations in sympathetic
`nervous system activity with intraoperative hypothermia during coro-
`nary artery bypass surgery. Chest. 1989;95:616-622.
`(4) Leaman PL, Martyak GG. Microwave warming of resuscitation
`fluids. Ann Emerg Med. 1985;14:876-879.
`(5) Norman EA, Ahmad I, Zeig NJ. Delivery temperature of heated
`and cooled intravenous solutions. Anesth Analg. 1986;65:693-699.
`(6) Skrivanek GD, Hein HAT. Fluid warming: Effectiveness with ex-
`tension tubing. Anesthesiology. 1986;65:A126. Abstract.
`(7) Aldrete JA. Preventing hypothermia in trauma patients by micro-
`wave warming of IV fluids. JEmerg Med. 1985;3:435-442.
`Jaeger RJ, Rubin RJ. Some pharmacologic and toxicologic effects
`(8)
`of di-2-ethylhexyl phthalate (DEHP) and other plasticizers. Environ
`Health Perspect. 1973;3:53-59.
`(9) Schulz CO, Rubin RJ, Hutchins GM. Acute pulmonary pathology
`and sudden death in rats following the intravenous administration of
`the plasticizer, di(2-ethylhexyl) phthalate, solubilized with Tween sur-
`factant. NASA. 1975;Cr-143803.
`Jaeger RJ, Rubin RJ. Migration of a phthalate ester plasticizer
`(11)
`from polyvinyl chloride blood bags into stored human blood and its
`localization in human tissues. NEnglJ Med. 1972;287:1114-1118.
`Jaeger RJ, Rubin RJ. Extraction, localization, and metabolism of
`(12)
`di-2-ethylhexyl phthalate from PVC plastic medical devices. Environ
`Health Perspect. 1973;3:95-102.
`(13) Gong V. Microwave warming of IV fluids in management of
`hypothermia. Ann Emerg Med. 1984;13:645. Letter.
`AUTHOR
`Lt Col C. Carl Bostek, CRNA, MSN, USAF, NC, is a senior anes-
`thetist at Minot AFB, North Dakota. He holds a BA from St. John's
`College, Santa Fe, New Mexico; a BSN from the University of Texas at
`Houston; and an MS in Physiology from the Medical College of Vir-
`ginia. He graduated from the U.S. Army Anesthesia School in 1979.
`The opinions stated in this article are solely those of the author
`and do not reflect the official opinions of the U.S. Air Force or the
`Department of Defense.
`
`566
`
`Journal
`
`of
`
`the American
`
`Association
`
`of Nurse
`
`Anesthetists
`
`Reactive Surfaces Ltd., LLP Ex. 1009 - Page 6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket